TCL Archive In Brief: Special Meeting To Review Viral Oncology Asked by DCCP Board; BCTF Budget: $8 Million October 31, 1980
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Large Studies Show Promising Results For Targeted Therapies Alimta, Tarceva June 26, 2009
